Müller-Eberhard H J
Biochem Soc Symp. 1985;50:235-46.
Five serum proteins act in concert to form the membrane attack complex (MAC) of complement. The precursor proteins, C5, C6, C7, C8 and C9, are hydrophilic glycoproteins with molecular weights ranging from 70,000 to 180,000. When C5 is cleaved by the serine protease C5 convertase, nascent C5b is produced which forms together with C6 a soluble and stable bimolecular complex (C5b,6). Upon binding of C5b,6 to C7 a trimolecular complex (C5b-7) is formed, which expresses a metastable membrane binding site. Membrane-bound C5b-7 constitutes the receptor for C8 and the tetramolecular C5b-8 complex binds and polymerizes C9. During the assembly process the proteins undergo hydrophilic-amphiphilic transition and the end product consists of C5b-8 (Mr approx. 550,000) and of tubular poly C9 (Mr approx. 1,100,000). The functional channel size varies but its maximal diameter is approximately 10 nm. C9 polymerization appears to involve initial reversible associations of several C9 molecules, which leads to temperature dependent, constrained unfolding. Unfolded C9 monomers then associate laterally with each other and polymerization terminates with closure of the circular structure, which consists of 12-18 C9 monomers. Amino acid composition and sequence indicate that the N-terminal half of the single chain C9 molecule is hydrophilic and the C-terminal half rather hydrophobic. Phospholipid binding and insertion into membranes are functions of the C-terminal portion of the molecule.
五种血清蛋白协同作用形成补体膜攻击复合物(MAC)。前体蛋白C5、C6、C7、C8和C9是亲水性糖蛋白,分子量在70,000至180,000之间。当C5被丝氨酸蛋白酶C5转化酶切割时,会产生新生的C5b,它与C6形成一种可溶性且稳定的双分子复合物(C5b,6)。C5b,6与C7结合后形成三分子复合物(C5b-7),该复合物表达一个亚稳态的膜结合位点。膜结合的C5b-7构成C8的受体,四分子的C5b-8复合物结合并使C9聚合。在组装过程中,这些蛋白质经历亲水性-两亲性转变,最终产物由C5b-8(分子量约550,000)和管状多聚C9(分子量约1,100,000)组成。功能性通道大小各异,但其最大直径约为10纳米。C9聚合似乎涉及几个C9分子最初的可逆缔合,这导致温度依赖性的受限展开。展开的C9单体随后彼此横向缔合,聚合随着由12 - 18个C9单体组成的环状结构的闭合而终止。氨基酸组成和序列表明,单链C9分子的N端一半是亲水的,C端一半则相当疏水。磷脂结合以及插入膜中是该分子C端部分的功能。